{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,5]],"date-time":"2024-06-05T00:29:37Z","timestamp":1717547377261},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,6,3]]},"DOI":"10.7759\/cureus.61614","type":"journal-article","created":{"date-parts":[[2024,6,4]],"date-time":"2024-06-04T00:03:56Z","timestamp":1717459436000},"source":"Crossref","is-referenced-by-count":0,"title":["Two Cases of Lung Abscess and Pleuritis in Severe COVID-19 Patients"],"prefix":"10.7759","author":[{"given":"Shiho","family":"Goda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuya","family":"Yuba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kohei","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Misaki","family":"Sasakura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noriya","family":"Hiraoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2020.07.016","article-title":"Bacterial co-infection and secondary infection in patients with COVID-19: a living rapid review and meta-analysis","volume":"26","author":"Langford BJ","year":"2020","unstructured":"Langford BJ, So M, Raybardhan S, et al.. Bacterial co-infection and secondary infection in patients with COVID-19: a living rapid review and meta-analysis. Clin Microbiol Infect. 2020, 26:1622-9. 10.1016\/j.cmi.2020.07.016","journal-title":"Clin Microbiol Infect"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2020.05.046","article-title":"Co-infections in people with COVID-19: a systematic review and meta-analysis","volume":"81","author":"Lansbury L","year":"2020","unstructured":"Lansbury L, Lim B, Baskaran V, Lim WS. Co-infections in people with COVID-19: a systematic review and meta-analysis. J Infect. 2020, 81:266-75. 10.1016\/j.jinf.2020.05.046","journal-title":"J Infect"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002\/ccr3.3686","article-title":"Lung abscess as a complication of COVID-19 infection, a case report","volume":"9","author":"Zamani N","year":"2021","unstructured":"Zamani N, Aloosh O, Ahsant S, Yassin Z, Abkhoo A, Riahi T. Lung abscess as a complication of COVID-19 infection, a case report. Clin Case Rep. 2021, 9:1130-4. 10.1002\/ccr3.3686","journal-title":"Clin Case Rep"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.resmer.2020.100776","article-title":"Delayed pulmonary abscess following COVID-19 pneumonia: a case report","volume":"78","author":"Renaud-Picard B","year":"2020","unstructured":"Renaud-Picard B, Gallais F, Riou M, Zouzou A, Porzio M, Kessler R. Delayed pulmonary abscess following COVID-19 pneumonia: a case report. Respir Med Res. 2020, 78:100776. 10.1016\/j.resmer.2020.100776","journal-title":"Respir Med Res"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)00676-0","article-title":"Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial","volume":"397","year":"2021","unstructured":"Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY). a randomised, controlled, open-label, platform trial. Lancet. 2021, 397:1637-45. 10.1016\/S0140-6736(21)00676-0","journal-title":"Lancet"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2030340","article-title":"Tocilizumab in patients hospitalized with Covid-19 pneumonia","volume":"384","author":"Salama C","year":"2021","unstructured":"Salama C, Han J, Yau L, et al.. Tocilizumab in patients hospitalized with Covid-19 pneumonia. N Engl J Med. 2021, 384:20-30. 10.1056\/NEJMoa2030340","journal-title":"N Engl J Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.eimc.2021.10.014","article-title":"COVID-19 associated infections in the ICU setting: a retrospective analysis in a tertiary-care hospital","volume":"41","author":"Ramos R","year":"2023","unstructured":"Ramos R, de la Villa S, Garc\u00eda-Ramos S, et al.. COVID-19 associated infections in the ICU setting: a retrospective analysis in a tertiary-care hospital. Enferm Infecc Microbiol Clin. 2023, 41:278-83. 10.1016\/j.eimc.2021.10.014","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics12071196","article-title":"Clinical and microbiological outcomes and follow-up of secondary bacterial and fungal infections among critically ill COVID-19 adult patients treated with and without immunomodulation: a prospective cohort study","volume":"12","author":"Szab\u00f3 BG","year":"2023","unstructured":"Szab\u00f3 BG, Cz\u00e9l E, Nagy I, et al.. Clinical and microbiological outcomes and follow-up of secondary bacterial and fungal infections among critically ill COVID-19 adult patients treated with and without immunomodulation: a prospective cohort study. Antibiotics (Basel). 2023, 12:10.3390\/antibiotics12071196","journal-title":"Antibiotics (Basel)"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-92220-0","article-title":"Secondary bacterial infection in COVID-19 patients is a stronger predictor for death compared to influenza patients","volume":"11","author":"Shafran N","year":"2021","unstructured":"Shafran N, Shafran I, Ben-Zvi H, et al.. Secondary bacterial infection in COVID-19 patients is a stronger predictor for death compared to influenza patients. Sci Rep. 2021, 11:12703. 10.1038\/s41598-021-92220-0","journal-title":"Sci Rep"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20201129","article-title":"SARS-CoV-2-triggered neutrophil extracellular traps mediate COVID-19 pathology","volume":"217","author":"Veras FP","year":"2020","unstructured":"Veras FP, Pontelli MC, Silva CM, et al.. SARS-CoV-2-triggered neutrophil extracellular traps mediate COVID-19 pathology. J Exp Med. 2020, 217:e20201129. 10.1084\/jem.20201129","journal-title":"J Exp Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1038\/ncprheum0338","article-title":"Interleukin 6: from bench to bedside","volume":"2","author":"Nishimoto N","year":"2006","unstructured":"Nishimoto N, Kishimoto T. Interleukin 6: from bench to bedside. Nat Clin Pract Rheumatol. 2006, 2:619-26. 10.1038\/ncprheum0338","journal-title":"Nat Clin Pract Rheumatol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11195559","article-title":"Is tocilizumab plus dexamethasone associated with superinfection in critically ill COVID-19 patients?","volume":"11","author":"Camou F","year":"2022","unstructured":"Camou F, Issa N, Hessamfar M, et al.. Is tocilizumab plus dexamethasone associated with superinfection in critically ill COVID-19 patients?. J Clin Med. 2022, 11:5559. 10.3390\/jcm11195559","journal-title":"J Clin Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.33421","article-title":"A potential novel treatment for chronic cough in long COVID patients: clearance of epipharyngeal residual SARS-CoV-2 spike RNA by epipharyngeal abrasive therapy","volume":"15","author":"Nishi K","year":"2023","unstructured":"Nishi K, Yoshimoto S, Tanaka T, Kimura S, Shinchi Y, Yamano T. A potential novel treatment for chronic cough in long COVID patients: clearance of epipharyngeal residual SARS-CoV-2 spike RNA by epipharyngeal abrasive therapy. Cureus. 2023, 15:e33421. 10.7759\/cureus.33421","journal-title":"Cureus"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.5606\/tftrd.2021.8208","article-title":"Staphylococcus aureus costochondritis and chest wall abscess in a COVID-19 patient treated with tocilizumab","volume":"67","author":"Ergen\u00e7 \u0130","year":"2021","unstructured":"Ergen\u00e7 \u0130, \u015eanal Toprak C, Odaba\u015f\u0131 Z. Staphylococcus aureus costochondritis and chest wall abscess in a COVID-19 patient treated with tocilizumab. Turk J Phys Med Rehabil. 2021, 67:382-5. 10.5606\/tftrd.2021.8208","journal-title":"Turk J Phys Med Rehabil"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.5152\/eurjrheum.2022.22028","article-title":"Severe infections in patients treated with tocilizumab for systemic diseases other than rheumatoid arthritis: a retrospective multicenter observational study","volume":"10","author":"Broca F","year":"2023","unstructured":"Broca F, Souchaud-Debouverie O, Liuu E, Roblot P, Martin M. Severe infections in patients treated with tocilizumab for systemic diseases other than rheumatoid arthritis: a retrospective multicenter observational study. Eur J Rheumatol. 2023, 10:18-22. 10.5152\/eurjrheum.2022.22028","journal-title":"Eur J Rheumatol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/257778-two-cases-of-lung-abscess-and-pleuritis-in-severe-covid-19-patients","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,4]],"date-time":"2024-06-04T00:03:58Z","timestamp":1717459438000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/257778-two-cases-of-lung-abscess-and-pleuritis-in-severe-covid-19-patients"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,3]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.61614","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6,3]]}}}